Efficacy News and Research

RSS
Telephone-based tinnitus-management program shows promise

Telephone-based tinnitus-management program shows promise

Top-line results from Neuraltus’ NP001 Phase 2 study on amyotrophic lateral sclerosis

Top-line results from Neuraltus’ NP001 Phase 2 study on amyotrophic lateral sclerosis

CINJ visiting scientist receives International - U.S. Annual Meeting Scientific Abstract Award

CINJ visiting scientist receives International - U.S. Annual Meeting Scientific Abstract Award

MiMedx third quarter revenue increases 270% to $8.0 million

MiMedx third quarter revenue increases 270% to $8.0 million

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Range of biopharma solutions from Malvern Instruments  extended by distribution agreement with Affinity Biosensors

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Triapine shows promise in treating breast cancer

Triapine shows promise in treating breast cancer

FDA clears MAQUET’s new SENSATION PLUS 7.5Fr. 40cc intra-aortic balloon catheter

FDA clears MAQUET’s new SENSATION PLUS 7.5Fr. 40cc intra-aortic balloon catheter

Drug-eluting stents exhibit some benefits in patients over 80

Drug-eluting stents exhibit some benefits in patients over 80

New anti-thrombotic treatments in AF patients can reduce risk of stroke

New anti-thrombotic treatments in AF patients can reduce risk of stroke

Combined antimicrobial and light therapy effective for treating foot ulcers

Combined antimicrobial and light therapy effective for treating foot ulcers

Hypnosis halts hot flashes

Hypnosis halts hot flashes

FDA approves 'first non-surgical treatment' for vitreomacular adhesion

FDA approves 'first non-surgical treatment' for vitreomacular adhesion

CUMC researchers develop first true mouse model of typhoid infection

CUMC researchers develop first true mouse model of typhoid infection

Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI

Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI

Aspirin can block tumor growth in certain patients with colorectal cancer

Aspirin can block tumor growth in certain patients with colorectal cancer

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

Patient and partner focus needed in rehab after prostatectomy

Patient and partner focus needed in rehab after prostatectomy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.